Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Oncology
Join Editorial Board Propose a Special Issue
Print ISSN: 1019-6439 Online ISSN: 1791-2423
Journal Cover
March-2022 Volume 60 Issue 3

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
March-2022 Volume 60 Issue 3

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Correction Open Access

[Corrigendum] DJ‑1 promotes cell proliferation and tumor metastasis in esophageal squamous cell carcinoma via the Wnt/β‑catenin signaling pathway

  • Authors:
    • Feng Jin
    • Haibo Wang
    • Dan Li
    • Chuanchi Fang
    • Wenyuan Li
    • Qingtong Shi
    • Yali Diao
    • Zhiyan Ding
    • Xiaojun Dai
    • Li Tao
    • Masataka Sunagawa
    • Feng Wu
    • Yayun Qian
    • Yanqing Liu
  • View Affiliations / Copyright

    Affiliations: Department of Respiratory Medicine, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, Jiangsu 225001, P.R. China, Institution of Combining Chinese Traditional and Western Medicine, Medical College, Yangzhou, Jiangsu 225009, P.R. China, Department of Thoracic Surgery, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, Jiangsu 225001, P.R. China, Department of Pathology, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, Jiangsu 225001, P.R. China, Department of Physiology, School of Medicine, Showa University, Tokyo 142-8555, Japan, Department of Respiratory Medicine, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, Jiangsu 225001, P.R. China
    Copyright: © Jin et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
  • Article Number: 30
    |
    Published online on: February 9, 2022
       https://doi.org/10.3892/ijo.2022.5320
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Article

Int J Oncol 56: [Related article:] 1115-1128, 2020; DOI: 10.3892/ijo.2020.5005

Subsequently to the publication of the above article, an interested reader drew to the authors' attention that a pair of data panels featured between Figs. 4 and 7 contained overlapping data such that the data were derived from the same original source where they were intending to depict the results from experiments performed under different experimental conditions, and a pair of the data panels featured in Fig. 8 for the β-catenin data also appeared to show overlapping data.

Figure 4

DJ-1 promotes EMT via the Wnt/β-catenin signaling pathway in esophageal squamous cell carcinoma. (A) LV-DJ-1 cells had a significantly higher migration and invasion ability compared with the control group (magnification, x200). (B) The adhesion ability was significantly increased in LV-DJ-1 cells. (C) DJ-1 overexpression promoted the EMT process by significantly reducing E-cadherin expression and significantly increasing the vimentin and N-cadherin expression. (D) LRP6, p-LRP6 and β-catenin expression were significantly upregulated, while Axin1 expression was significantly downregulated in LV-DJ-1 cells. The ratio of p-LRP6 to total LRP6 protein exhibited no significant change between the control group and DJ-1 overexpression group. *P<0.05, **P<0.01 vs. LV-con. LV-DJ-1, lentivirus overexpressing DJ-1; LV-con, lentivirus control; LRP-6, lipoprotein receptor-related protein 6; p-. phosphorylated.

Figure 7

Inhibition of Wnt/β-catenin reduces tumor malignant behaviors caused by DJ-1. (A) The proliferation of LV-DJ-1 cells treated with XAV939 was significantly decreased compared with LV-DJ-1 cells (magnification, x100). (B) In the colony formation assay, cells treated with XAV939 had fewer colonies compared with the control LV-DJ-1 cells (magnification, x100). (C) In the Transwell assay, cells of the LV-DJ-1 + XAV939 group demonstrated a weaker ability to migrate and invade compared with the LV-DJ-1 group (magnification, x200). (D) The adhesion ability was decreased in the LV-DJ-1 + XAV939 group compared with the LV-DJ-1 group. (E) Western blotting results demonstrated XAV939 treatment could increase the E-cadherin expression, while it reduced the vimentin and N-cadherin expression levels. (F) LRP6, p-LRP6 and β-catenin expression were downregulated, while Axin1 expression was upregulated in XAV939-treated compared with control cells. The ratio of p-LRP6 to total LRP6 protein was significantly increased in XAV939-treated cells compared with the control untreated LV-DJ-1 cells. *P<0.05, **P<0.01 vs. LV-DJ-1 group. LV-DJ-1, lentivirus overexpressing DJ-1; LRP-6, lipoprotein receptor-related protein 6; p-. phosphorylated.

Figure 8

Manipulation of DJ-1 expression influences esophageal squamous cell carcinoma xenograft metastasis and EMT via the Wnt/β-catenin signal pathway. (A) The number of peritoneal dissemination nodules in the LV-DJ-1 group was significantly higher compared with the LV-con group. **P<0.01 vs. LV-con. (B) In LV-siRNA-DJ-1 group, the number of peritoneal dissemination nodules was significantly lower compared with the LV-siRNA-con group. **P<0.01 vs. LV-siRNA-DJ-1. (C) Liver metastases in the LV-DJ-1 group exhibited a larger volume and more nodules. (D) In the LV-siRNA-DJ-1 group, liver metastases exhibited a smaller volume and fewer nodules. (E) Immunohistochemistry results revealed increased DJ-1, vimentin and β-catenin, and decreased E-cadherin levels in the LV-DJ-1 group, and decreased DJ-1, vimentin and β-catenin, and increased E-cadherin levels in the LV-siRNA-DJ-1 group (magnification, x200). LV-DJ-1, lentivirus overexpressing DJ-1; LV-con, lentivirus control; LV-siRNA-DJ-1, lentivirus encoding DJ-1 small interfering RNA; LV-siRNA-con, lentivirus encoding control small interfering RNA.

The authors were able to re-examine their original data, and have identified the data that were intended to have been shown for these figure parts. The corrected versions of Fig. 4 (showing the correct data for the LV-DJ-1/migration experiment in Fig. 4A), Fig. 7 (showing the correct data for the LV-DJ-1 + XAV939/migration experiment) and Fig. 8 (showing the correct data for the LV-siRNA-DJ-1 experiment) are shown on the subsequent pages. The authors confirm that these inadvertent errors did not have any major impact on the conclusions reported in their paper, are grateful to the Editor of International Journal of Oncology for allowing them the opportunity to publish this Corrigendum, and apologize to the readership for any inconvenience caused.

Figure 4

DJ-1 promotes EMT via the Wnt/β-catenin signaling pathway in esophageal squamous cell carcinoma. (A) LV-DJ-1 cells had a significantly higher migration and invasion ability compared with the control group (magnification, x200). (B) The adhesion ability was significantly increased in LV-DJ-1 cells. (C) DJ-1 overexpression promoted the EMT process by significantly reducing E-cadherin expression and significantly increasing the vimentin and N-cadherin expression. (D) LRP6, p-LRP6 and β-catenin expression were significantly upregulated, while Axin1 expression was significantly downregulated in LV-DJ-1 cells. The ratio of p-LRP6 to total LRP6 protein exhibited no significant change between the control group and DJ-1 overexpression group. *P<0.05, **P<0.01 vs. LV-con. LV-DJ-1, lentivirus overexpressing DJ-1; LV-con, lentivirus control; LRP-6, lipoprotein receptor-related protein 6; p-. phosphorylated.

Figure 7

Inhibition of Wnt/β-catenin reduces tumor malignant behaviors caused by DJ-1. (A) The proliferation of LV-DJ-1 cells treated with XAV939 was significantly decreased compared with LV-DJ-1 cells (magnification, x100). (B) In the colony formation assay, cells treated with XAV939 had fewer colonies compared with the control LV-DJ-1 cells (magnification, x100). (C) In the Transwell assay, cells of the LV-DJ-1 + XAV939 group demonstrated a weaker ability to migrate and invade compared with the LV-DJ-1 group (magnification, x200). (D) The adhesion ability was decreased in the LV-DJ-1 + XAV939 group compared with the LV-DJ-1 group. (E) Western blotting results demonstrated XAV939 treatment could increase the E-cadherin expression, while it reduced the vimentin and N-cadherin expression levels. (F) LRP6, p-LRP6 and β-catenin expression were downregulated, while Axin1 expression was upregulated in XAV939-treated compared with control cells. The ratio of p-LRP6 to total LRP6 protein was significantly increased in XAV939-treated cells compared with the control untreated LV-DJ-1 cells. *P<0.05, **P<0.01 vs. LV-DJ-1 group. LV-DJ-1, lentivirus overexpressing DJ-1; LRP-6, lipoprotein receptor-related protein 6; p-. phosphorylated.

Figure 8

Manipulation of DJ-1 expression influences esophageal squamous cell carcinoma xenograft metastasis and EMT via the Wnt/β-catenin signal pathway. (A) The number of peritoneal dissemination nodules in the LV-DJ-1 group was significantly higher compared with the LV-con group. **P<0.01 vs. LV-con. (B) In LV-siRNA-DJ-1 group, the number of peritoneal dissemination nodules was significantly lower compared with the LV-siRNA-con group. **P<0.01 vs. LV-siRNA-DJ-1. (C) Liver metastases in the LV-DJ-1 group exhibited a larger volume and more nodules. (D) In the LV-siRNA-DJ-1 group, liver metastases exhibited a smaller volume and fewer nodules. (E) Immunohistochemistry results revealed increased DJ-1, vimentin and β-catenin, and decreased E-cadherin levels in the LV-DJ-1 group, and decreased DJ-1, vimentin and β-catenin, and increased E-cadherin levels in the LV-siRNA-DJ-1 group (magnification, x200). LV-DJ-1, lentivirus overexpressing DJ-1; LV-con, lentivirus control; LV-siRNA-DJ-1, lentivirus encoding DJ-1 small interfering RNA; LV-siRNA-con, lentivirus encoding control small interfering RNA.

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Jin F, Wang H, Li D, Fang C, Li W, Shi Q, Diao Y, Ding Z, Dai X, Tao L, Tao L, et al: [Corrigendum] DJ‑1 promotes cell proliferation and tumor metastasis in esophageal squamous cell carcinoma via the Wnt/β‑catenin signaling pathway. Int J Oncol 60: 30, 2022.
APA
Jin, F., Wang, H., Li, D., Fang, C., Li, W., Shi, Q. ... Liu, Y. (2022). [Corrigendum] DJ‑1 promotes cell proliferation and tumor metastasis in esophageal squamous cell carcinoma via the Wnt/β‑catenin signaling pathway. International Journal of Oncology, 60, 30. https://doi.org/10.3892/ijo.2022.5320
MLA
Jin, F., Wang, H., Li, D., Fang, C., Li, W., Shi, Q., Diao, Y., Ding, Z., Dai, X., Tao, L., Sunagawa, M., Wu, F., Qian, Y., Liu, Y."[Corrigendum] DJ‑1 promotes cell proliferation and tumor metastasis in esophageal squamous cell carcinoma via the Wnt/β‑catenin signaling pathway". International Journal of Oncology 60.3 (2022): 30.
Chicago
Jin, F., Wang, H., Li, D., Fang, C., Li, W., Shi, Q., Diao, Y., Ding, Z., Dai, X., Tao, L., Sunagawa, M., Wu, F., Qian, Y., Liu, Y."[Corrigendum] DJ‑1 promotes cell proliferation and tumor metastasis in esophageal squamous cell carcinoma via the Wnt/β‑catenin signaling pathway". International Journal of Oncology 60, no. 3 (2022): 30. https://doi.org/10.3892/ijo.2022.5320
Copy and paste a formatted citation
x
Spandidos Publications style
Jin F, Wang H, Li D, Fang C, Li W, Shi Q, Diao Y, Ding Z, Dai X, Tao L, Tao L, et al: [Corrigendum] DJ‑1 promotes cell proliferation and tumor metastasis in esophageal squamous cell carcinoma via the Wnt/β‑catenin signaling pathway. Int J Oncol 60: 30, 2022.
APA
Jin, F., Wang, H., Li, D., Fang, C., Li, W., Shi, Q. ... Liu, Y. (2022). [Corrigendum] DJ‑1 promotes cell proliferation and tumor metastasis in esophageal squamous cell carcinoma via the Wnt/β‑catenin signaling pathway. International Journal of Oncology, 60, 30. https://doi.org/10.3892/ijo.2022.5320
MLA
Jin, F., Wang, H., Li, D., Fang, C., Li, W., Shi, Q., Diao, Y., Ding, Z., Dai, X., Tao, L., Sunagawa, M., Wu, F., Qian, Y., Liu, Y."[Corrigendum] DJ‑1 promotes cell proliferation and tumor metastasis in esophageal squamous cell carcinoma via the Wnt/β‑catenin signaling pathway". International Journal of Oncology 60.3 (2022): 30.
Chicago
Jin, F., Wang, H., Li, D., Fang, C., Li, W., Shi, Q., Diao, Y., Ding, Z., Dai, X., Tao, L., Sunagawa, M., Wu, F., Qian, Y., Liu, Y."[Corrigendum] DJ‑1 promotes cell proliferation and tumor metastasis in esophageal squamous cell carcinoma via the Wnt/β‑catenin signaling pathway". International Journal of Oncology 60, no. 3 (2022): 30. https://doi.org/10.3892/ijo.2022.5320
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team